Arkansas 2023 Regular Session

Arkansas House Bill HB1271 Compare Versions

OldNewDifferences
11 Stricken language would be deleted from and underlined language would be added to present law.
2-Act 575 of the Regular Session
32 *ANS167* 03-16-2023 15:14:00 ANS167
43
54 State of Arkansas As Engrossed: H3/6/23 H3/9/23 S3/16/23 1
65 94th General Assembly A Bill 2
76 Regular Session, 2023 HOUSE BILL 1271 3
87 4
98 By: Representatives L. Johnson, Achor, F. Allen, Bentley, Breaux, K. Brown, M. Brown, Joey Carr, 5
109 Cavenaugh, Duffield, Ennett, Eubanks, D. Ferguson, V. Flowers, D. Garner, Gramlich, Hawk, G. 6
1110 Hodges, Hollowell, Ladyman, Long, J. Mayberry, McAlindon, McGrew, B. McKenzie, S. Meeks, J. 7
1211 Moore, Painter, Pilkington, J. Richardson, R. Scott Richardson, Richmond, Rye, Underwood, Vaught, 8
1312 Wardlaw, D. Whitaker, Womack, Wooten 9
1413 By: Senators Irvin, J. Boyd 10
1514 11
1615 For An Act To Be Entitled 12
1716 AN ACT TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY 13
1817 ACT; TO EXEMPT CERTA IN HEALTHCARE PROVID ERS THAT 14
1918 PROVIDE CERTAIN HEAL THCARE SERVICES FROM PRIOR 15
2019 AUTHORIZATION REQUIR EMENTS; AND FOR OTHE R PURPOSES. 16
2120 17
2221 18
2322 Subtitle 19
2423 TO AMEND THE PRIOR AUTHORIZATION 20
2524 TRANSPARENCY ACT; AND TO EXEMPT CERTAIN 21
2625 HEALTHCARE PROVIDERS THAT PROVIDE CERTAIN 22
2726 HEALTHCARE SERVICES FROM PRIOR 23
2827 AUTHORIZATION REQUIREMENTS. 24
2928 25
3029 26
3130 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS: 27
3231 28
3332 SECTION 1. Arkansas Code § 23-99-1103(8), concerning the definition of 29
3433 "healthcare insurer" under the Prior Authorization Transparency Act, is 30
3534 amended to read as follows: 31
3635 (8)(A)(i) “Healthcare insurer” means an entity that is subject 32
3736 to state insurance regulation, including an insurance company, a health 33
3837 maintenance organization, a hospital and medical service corporation, a risk-34
3938 based provider organization, and a sponsor of a nonfederal self-funded 35
4039 governmental plan. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
4140
4241 2 03-16-2023 15:14:00 ANS167
4342
4443
4544 (ii) “Healthcare insurer” includes Medicaid where 1
4645 specifically referenced in §§ 23-99-1119 — 23-99-1126. 2
4746 (B) “Healthcare insurer” does not include: 3
4847 (i) A workers' compensation plan; 4
4948 (ii) Medicaid, except as provided under §§ 23-99-5
5049 1119 — 23-99-1126 or when Medicaid services are managed or reimbursed by a 6
5150 healthcare insurer; or 7
5251 (iii) An entity that provides only dental benefits 8
5352 or eye and vision care benefits; 9
5453 10
5554 SECTION 2. Arkansas Code § 23 -99-1103, concerning definitions used 11
5655 under the Prior Authorization Transparency Act, is amended to add additional 12
5756 subdivisions to read as follows: 13
5857 (22) "Random sample" means at least five (5) claims but no more 14
5958 than twenty (20) claims for a particular healthcare service that are selected 15
6059 without method or conscious decision; and 16
6160 (23) "Value-based reimbursement" means reimbursement that: 17
6261 (A) Ties a payment for the provision of healthcare 18
6362 services to the quality of health care provided; 19
6463 (B) Rewards a healthcare provider for efficiency and 20
6564 effectiveness; and 21
6665 (C) May impose a risk -sharing requirement on a healthcare 22
6766 provider for healthcare services that do not meet the healthcare insurer's 23
6867 requirements for quality, effectiveness, and efficiency. 24
6968 25
7069 SECTION 3. Arkansas Code § 23 -99-1104(a)(1), concerning disclosure 26
7170 required under the Prior Au thorization Transparency Act, is amended to read 27
7271 as follows: 28
7372 (a)(1)(A) A utilization review entity shall disclose all of its prior 29
7473 authorization requirements and restrictions, including any written clinical 30
7574 criteria, in a publicly accessible manner on its website. 31
7675 (B) The disclosure under subdivision (a)(1)(A) of this 32
7776 section shall include: 33
7877 (i) A list of any healthcare services that require 34
7978 prior authorization; and 35
8079 (ii) Any written clinical criteria. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
8180
8281 3 03-16-2023 15:14:00 ANS167
8382
8483
8584 1
8685 SECTION 4. Arkansas Code § 23 -99-1111 is amended to read as follows: 2
8786 23-99-1111. Requests for prior authorization — Qualified persons 3
8887 authorized to review and approve — Adverse determinations to be made only by 4
8988 Arkansas-licensed physicians — Opportunity to discuss treatment before 5
9089 adverse determination . 6
9190 (a) The initial review of information submitted in support of a 7
9291 request for prior authorization may be conducted by a qualified person 8
9392 employed or contracted by a utilization review entity. 9
9493 (b) A request for prior authorization may be approved by a qualified 10
9594 person employed or contracted by a utilization review entity. 11
9695 (c)(1) An adverse determination regarding a request for prior 12
9796 authorization shall be made by a physician who possesses a current and 13
9897 unrestricted license to practice medicine in the State of Arkansas issued by 14
9998 the Arkansas State Medical Board. 15
10099 (2)(A) A utilization review entity shall provide a method by 16
101100 which a physician may request that a prior authorization request be reviewed 17
102101 by a physician in the same specialty as the physician making the request, by 18
103102 a physician in another appropriate specialty, or by a pharmacologist. 19
104103 (B) If a request is made under subdivision (c)(2)(A) of 20
105104 this section, the reviewing physician or pharmacologist is not required to 21
106105 meet the requirements of subdivision (c)(1) of this section. 22
107106 (3)(A) Subject to this subdivision (c)(3), when an adverse 23
108107 determination is issued by a utilization review entity that questions the 24
109108 medical necessity, the appropriateness, or the experimental or 25
110109 investigational nature of a healthcare service, the utilization review entity 26
111110 shall provide in the notice of adverse determination the name and telephone 27
112111 number of a physician who possesses a current and unrestricted license i n 28
113112 this state with whom the requesting healthcare provider may have a reasonable 29
114113 opportunity to discuss the patient's treatment plan and the clinical basis 30
115114 for the intervention. 31
116115 (B) The requesting healthcare provider may contact the 32
117116 reviewing physician at the telephone number provided with the adverse 33
118117 determination under subdivision (c)(3)(A) of this section within one (1) 34
119118 business day of receipt of the adverse determination for an urgent service, 35
120119 or within two (2) business days of receipt of the adverse determination for a 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
121120
122121 4 03-16-2023 15:14:00 ANS167
123122
124123
125124 nonurgent service, to engage in the discussion of the patient's treatment 1
126125 plan and the clinical basis for the intervention under subdivision (c)(3)(A) 2
127126 of this section. 3
128127 (C)(i) Following any discussion under subdivision 4
129128 (c)(3)(B) of this section, the utilization review entity shall notify the 5
130129 healthcare provider whether or not the adverse determination decision remains 6
131130 the same or the service is approved. 7
132131 (ii) The notice under subdivision (c)(3)(C)(i) of 8
133132 this section shall be pro vided: 9
134133 (a) Within one (1) business day of the 10
135134 discussion under subdivision (c)(3)(B) of this section between the provider 11
136135 and physician for an urgent service; or 12
137136 (b) Within two (2) business days of the 13
138137 discussion under subdivision (c)(3)(B) of this section between the provider 14
139138 and physician for a nonurgent service. 15
140139 (D) A discussion under subdivision (c)(3)(A) of this 16
141140 section shall not replace or eliminate the opportunity for any internal 17
142141 grievance or appeal process provided by the utilizatio n review entity. 18
143142 (E) If a requesting healthcare provider is a physician, 19
144143 then the reviewing physician with whom the requesting physician is given an 20
145144 opportunity to discuss the treatment plan and clinical basis for the 21
146145 intervention under subdivision (c)(3)(B) of this section shall be a physician 22
147146 who: 23
148147 (i) Possesses a current and unrestricted 24
149148 license to practice medicine in this state; and 25
150149 (ii) Has the same or similar specialty as the 26
151150 healthcare provider. 27
152151 28
153152 SECTION 5. Arkansas Code Title 23 , Chapter 99, Subchapter 11, is 29
154153 amended to add additional sections to read as follows: 30
155154 23-99-1120. Initial exemption from prior authorization requirements 31
156155 for healthcare providers providing certain healthcare services. 32
157156 (a)(1) Except as provided under s ubdivision (a)(2) of this section, 33
158157 beginning on and after January 1, 2024, a healthcare provider that received 34
159158 approval for ninety percent (90%) or more of the healthcare provider's prior 35
160159 authorization requests based on a review of the healthcare provider' s 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
161160
162161 5 03-16-2023 15:14:00 ANS167
163162
164163
165164 utilization of the particular healthcare services from January 1, 2022, 1
166165 through June 30, 2022, shall not be required to obtain prior authorization 2
167166 for a particular healthcare service and shall be considered exempt from prior 3
168167 authorization requirements th rough September 30, 2024. 4
169168 (2) If a healthcare provider's use for a particular healthcare 5
170169 service increases by twenty -five percent (25%) or more during the period 6
171170 between January 1, 2024, and June 30, 2024, based on a review of the 7
172171 healthcare provider's utilization of the particular healthcare service from 8
173172 January 1, 2022, through June 30, 2022, then the healthcare insurer may 9
174173 disallow the exemption from prior authorization requirements for the 10
175174 healthcare provider for the particular healthcare service. 11
176175 (b)(1) A healthcare insurer shall conduct an evaluation of the initial 12
177176 six-month exemption period based on claims submitted between January 1, 2024, 13
178177 through June 30, 2024, to determine whether to grant or deny an exemption for 14
179178 each particular healthcare service that requires a prior authorization by the 15
180179 healthcare insurer. 16
181180 (2) The evaluation by the healthcare insurer shall be conducted 17
182181 by using the retrospective review process under § 23 -99-1122(c) and applying 18
183182 the criteria under s ubsection (d) of this section. 19
184183 (3) A healthcare insurer shall submit to a healthcare provider a 20
185184 written statement of: 21
186185 (A) The total number of payable claims submitted by or in 22
187186 connection with the healthcare provider; and 23
188187 (B) The total number of denied and approved prior 24
189188 authorizations between January 1, 2022, through June 30, 2022. 25
190189 (c)(1) No later than October 1, 2024, a healthcare insurer shall issue 26
191190 a notice to each healthcare provider that either grants or denies a prior 27
192191 authorization exemption to the healthcare provider for each particular 28
193192 healthcare service. 29
194193 (2) An exemption granted under this subdivision (c)(1) shall be 30
195194 valid for at least twelve (12) months. 31
196195 (d) Except as provided under subsection (f) of this section or § 23 -32
197196 99-1125, a healthcare insurer that uses a prior authorization process for 33
198197 healthcare services shall not require a healthcare provider to obtain prior 34
199198 authorization for a particular health care service that a healthcare provider 35
200199 has previously been subject to a prior authorization requirement if, in the 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
201200
202201 6 03-16-2023 15:14:00 ANS167
203202
204203
205204 most recent six-month evaluation period as described under subsection (e) of 1
206205 this section, the healthcare insurer has approved or would have approved no 2
207206 less than ninety percent (90%) of the prior authorization requests submitted 3
208207 by the healthcare provider for that particular healthcare service. 4
209208 (e)(1) Except as provided under subsection (f) of this section, a 5
210209 healthcare insurer shall evalua te whether or not a healthcare provider 6
211210 qualifies for an exemption from prior authorization requirements under 7
212211 subsection (d) of this section one (1) time every twelve (12) months. 8
213212 (2) The six-month period for the evaluation period described 9
214213 under subsection (d) of this section shall be any consecutive six (6) month 10
215214 period during the twelve (12) months following the effective date of the 11
216215 exemption. 12
217216 (3) The healthcare insurer shall choose a six -month evaluation 13
218217 period that allows time for: 14
219218 (A) The evaluation under subsection (d) of this section; 15
220219 (B) Notice to the healthcare provider of the decision; and 16
221220 (C) Appeal of the decision for an independent review to be 17
222221 completed by the end of the twelve -month period of the exemption. 18
223222 (f) A healthcare insurer may continue an exemption under subsection 19
224223 (d) of this section without evaluating whether or not the healthcare provider 20
225224 qualifies for the exemption under subsection (d) of this section for a 21
226225 particular evaluation period. 22
227226 (g) A healthcare provider is not required to request an exemption 23
228227 under subsection (d) of this section to quality for the exemption. 24
229228 (h) A healthcare insurer may extend an exemption under subsection (d) 25
230229 of this section to a group of healthcare providers under the same tax 26
231230 identification number if: 27
232231 (1) A healthcare provider with an ownership interest in the 28
233232 entity to which the tax identification number is assigned does not object; or 29
234233 (2) The tax identification number is associated with a hospital 30
235234 licensed in this state and the chief executive officer of the hospital agrees 31
236235 to the exemption. 32
237236 33
238237 23-99-1121. Duration of prior authorization exemption. 34
239238 (a) Unless a prior authorization exemption is continued for a longer 35
240239 period of time by a healthcare insurer under § 23-99-1120(f), a healthcare 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
241240
242241 7 03-16-2023 15:14:00 ANS167
243242
244243
245244 provider's exemption from prior authorization requirements under § 23-99-1120 1
246245 remains in effect until the later of: 2
247246 (1) The thirtieth day after the date the healthcare insurer 3
248247 notifies the healthcare provider of the healthcare insurer's determination to 4
249248 rescind the exemption as described under § 23-99-1122, if the healthcare 5
250249 provider does not appeal the healthcare insurer's determination within thirty 6
251250 (30) days of notification of the determination; 7
252251 (2) If the healthcare provider appeals the determination within 8
253252 thirty (30) days of notification of the determination, the fifth day after 9
254253 the date an independent review organization affirms the healthcare insurer's 10
255254 determination to rescind the exemption; or 11
256255 (3) Twelve (12) months after the effective date of the 12
257256 exemption. 13
258257 (b) If a healthcare provider appeals the determination to rescind the 14
259258 exemption more than thirty (30) days after notification of the determination 15
260259 and the independent review organization overtu rns the rescission, the 16
261260 healthcare provider’s exemption is restored the fifth day after the date of 17
262261 the independent review organization’s decision, and the exemption remains in 18
263262 effect for twelve (12) months after restoration unless rescinded under § 23 -19
264263 99-1122. 20
265264 (c) If a healthcare insurer does not finalize a rescission 21
266265 determination as specified in subsection (a) of this section, then the 22
267266 healthcare provider is considered to have met the criteria under § 23-99-1120 23
268267 to continue to qualify for the exemption. 24
269268 (d) A healthcare provider shall not rely on another healthcare 25
270269 provider’s exemption except when the healthcare provider with an exemption is 26
271270 the healthcare provider that orders healthcare services that are rendered by 27
272271 a healthcare provider without an exemption. 28
273272 29
274273 23-99-1122. Denial or rescission of prior authorization exemption. 30
275274 (a) A healthcare insurer may rescind an exemption from prior 31
276275 authorization requirements of a healthcare provider under § 23-99-1120 only 32
277276 if: 33
278277 (1) The healthcare insurer makes a determination that, on the 34
279278 basis of a retrospective review of a random sample of claims selected by the 35
280279 healthcare insurer during the most recent evaluation period described by § 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
281280
282281 8 03-16-2023 15:14:00 ANS167
283282
284283
285284 23-99-1120(e), less than ninety percent (90%) of the claims for the 1
286285 particular healthcare service met the medical necessity criteria that would 2
287286 have been used by the healthcare insurer when conducting prior authorization 3
288287 review for the particular healthcare service during the relevant evaluation 4
289288 period; 5
290289 (2) The healthcare insurer complies with other applicable 6
291290 requirements specified in this section, including without limitation: 7
292291 (A) Notifying the healthcare provider no less than twenty-8
293292 five (25) days before the proposed rescission is to take effect; and 9
294293 (B) Providing: 10
295294 (i) An identification of the healthcare service that 11
296295 an exemption is being rescinded, the date the notice is issued, and the 12
297296 effective date of the rescission; 13
298297 (ii) A plain-language explanation of how the 14
299298 healthcare provider may appeal and seek an ind ependent review of the 15
300299 determination, the date the notice is issued, and the company’s address and 16
301300 contact information for returning the form by mail or email to request an 17
302301 appeal; 18
303302 (iii) A statement of the total number of payable 19
304303 claims submitted by or in connection with the healthcare provider during the 20
305304 most recent evaluation period that were eligible to be evaluated with respect 21
306305 to the healthcare service subject to rescission, the number of claims 22
307306 included in the random sample, and the sample infor mation used to make the 23
308307 determination, including without limitation: 24
309308 (a) Identification of each claim included in 25
310309 the random sample; 26
311310 (b) The healthcare insurer’s determination of 27
312311 whether each claim met the healthcare insurer’s screening criteri a; and 28
313312 (c) For any claim determined to not have met 29
314313 the healthcare insurer’s screening criteria: 30
315314 (1) The principal reasons for the 31
316315 determination that the claim did not meet the healthcare insurer’s screening 32
317316 criteria, including, if applicable, a statement that the determination was 33
318317 based on a failure to submit specified medical records; 34
319318 (2) The clinical basis for the 35
320319 determination that the claim did not meet the healthcare insurer’s screening 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
321320
322321 9 03-16-2023 15:14:00 ANS167
323322
324323
325324 criteria; 1
326325 (3) A description of the sou rces of the 2
327326 screening criteria that were used as guidelines in making the determination; 3
328327 and 4
329328 (4) The professional specialty of the 5
330329 healthcare provider who made the determination; 6
331330 (iv) A space to be filled out by the healthcare 7
332331 provider that includes: 8
333332 (a) The name, address, contact information, 9
334333 and identification number of the healthcare provider requesting an 10
335334 independent review; 11
336335 (b) An indication of whether or not the 12
337336 healthcare provider is requesting that the entity performing the i ndependent 13
338337 review examine the same random sample or a different random sample of claims, 14
339338 if available; and 15
340339 (c) The date the appeal is being requested; 16
341340 and 17
342341 (v) An instruction to the healthcare provider to 18
343342 return the form to the healthcare insurer before the date the rescission 19
344343 becomes effective; and 20
345344 (3) The healthcare provider performs five (5) or fewer of a 21
346345 particular healthcare service in the most recent six -month evaluation period 22
347346 under § 23-99-1120(e). 23
348347 (b) A determination made under subdivision (a)(1) of this section 24
349348 shall be made by a physician who: 25
350349 (1) Possesses a current and unrestricted license to practice 26
351350 medicine in this state; and 27
352351 (2) Has the same or similar specialty as the healthcare 28
353352 provider. 29
354353 (c)(1) A healthcare insu rer that is conducting an evaluation under 30
355354 subsection (a) of this section to determine whether or not a healthcare 31
356355 provider still qualifies for a prior authorization exemption may request 32
357356 medical records and documents required for the retrospective review, limited 33
358357 to no more than twenty (20) claims for a particular healthcare service. 34
359358 (2) A healthcare insurer shall provide a healthcare provider at 35
360359 least thirty (30) days to provide the medical records requested under 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
361360
362361 10 03-16-2023 15:14:00 ANS167
363362
364363
365364 subdivision (c)(1) of this section. 1
366365 (d) A healthcare insurer may deny an exemption from prior 2
367366 authorization requirements under § 23-99-1120 only if: 3
368367 (1) The healthcare provider does not have an exemption at the 4
369368 time of the relevant evaluation period; and 5
370369 (2) The healthcare insurer provides the healthcare provider 6
371370 with: 7
372371 (A) Actual data for the relevant prior authorization 8
373372 request evaluation period; and 9
374373 (B) Detailed information sufficient to demonstrate that 10
375374 the healthcare provider does not meet the criteria for an exemption from 11
376375 prior authorization requirements for the particular healthcare service under 12
377376 § 23-99-1120. 13
378377 (e) A healthcare insurer shall: 14
379378 (1) Allow a healthcare provider to designate an email address or 15
380379 a mailing address for communications regarding exemptions, denials, and 16
381380 rescissions; 17
382381 (2) Provide an option for a healthcare provider to submit a 18
383382 request for an appeal by mail, by email, or by other electronic method; and 19
384383 (3) Include an explanation of how a healthcare provider may 20
385384 update his or her preferred contact information and delivery method on the 21
386385 healthcare insurer's website and for all communications issued under this 22
387386 section. 23
388387 24
389388 23-99-1123. Independent review of exemption determination. 25
390389 (a)(1) A healthcare provider has a right to a review of an adverse 26
391390 determination regarding a prior authorization exemption within twelve (12) 27
392391 months of receiving proper notice of recission from a healthcare insurer to 28
393392 be conducted by an independent review organization. 29
394393 (2) A healthcare insurer shall not require a healthcare provider 30
395394 to engage in an internal appeal process before requesting a review by an 31
396395 independent review organization under this section. 32
397396 (3) A healthcare provider who has an exemption rescinded due to 33
398397 a failure to provide medical records within sixty (60) days of a record 34
399398 request for a retrospective review shall not be eligible for review of that 35
400399 rescission by an independent review entity. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
401400
402401 11 03-16-2023 15:14:00 ANS167
403402
404403
405404 (b) A healthcare insurer shall pay: 1
406405 (1) For any appeal or independent review of an adverse 2
407406 determination regarding a prior authorization exemption requested under this 3
408407 section; and 4
409408 (2) A reasonable fee determined by the Arkansas State Medical 5
410409 Board for any copies of medical records or other documents requested from a 6
411410 healthcare provider during an exemption rescission review requested under 7
412411 this section. 8
413412 (c) An independent review organization shall complete an expedited 9
414413 review of an adverse determination regarding a prior authorization exemption 10
415414 no later than the thirtieth day after the date a healthcare provider files 11
416415 the request for a review under this section. 12
417416 (d)(1) A healthcare provider may request that the independent review 13
418417 organization consider another random sample of no fewer than five (5) and no 14
419418 more than twenty (20) claims submitted to the healthcare insurer by the 15
420419 healthcare provider during the relevant evaluation period for the relevant 16
421420 healthcare service as part of the review under this section. 17
422421 (2) If a healthcare provider makes a request under subdivision 18
423422 (d)(1) of this section, the independent review organization shall base its 19
424423 determination on the medical necessity of claims reviewed: 20
425424 (A) By the healthcare insurer under § 23-99-1122; and 21
426425 (B) By the independent review organization under 22
427426 subdivision (d)(1) of this section. 23
428427 (e) The Insurance Commissioner may refuse, suspend, revoke, or not 24
429428 renew a license or certificate of authority of a healthcare insurer that has 25
430429 fifty percent (50%) of healthcare provider appeals overturned in a twelve -26
431430 month period by an independent review organization under this section. 27
432431 28
433432 23-99-1124. Effect of appeal of independent review organization 29
434433 determination. 30
435434 (a) A healthcare insurer is bound by an appeal or independent review 31
436435 organization determination that does not affirm the determination made by the 32
437436 healthcare insurer to rescind a prior authorization exemption. 33
438437 (b) A healthcare insurer shall not retroactively deny a healthcare 34
439438 service on the basis of a rescission of an exemption, even if the healthcare 35
440439 insurer's determination to rescind the prior authorization exemption is 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
441440
442441 12 03-16-2023 15:14:00 ANS167
443442
444443
445444 affirmed by an independent review organization. 1
446445 (c) If a determination of a prior authorization exemption made by the 2
447446 healthcare insurer is overturned on review by an independent review 3
448447 organization, the healthcare insurer: 4
449448 (1) Shall not attempt to rescind the exemption before the end of 5
450449 the next evaluation period; and 6
451450 (2) May only rescind the exemption if the healthcare insurer 7
452451 complies with §§ 23-99-1122 and 23-99-1123. 8
453452 9
454453 23-99-1125. Eligibility for prior authorization exemption following 10
455454 finalized exemption rescission or denial. 11
456455 (a) After a final determination or review affirming the rescission or 12
457456 denial of an exemption for a specific healthcare service under § 23-99-1120, 13
458457 a healthcare insurer shall conduct another evaluation to determine whether or 14
459458 not the exemption should be granted or reinstated based on the six-month 15
460459 evaluation period that follows the evaluation period that formed the basis of 16
461460 the rescission or denial of an exemption. 17
462461 (b) A time period that is included in a previous evaluation or 18
463462 determination period shall not be included in a subsequent evaluation period. 19
464463 20
465464 23-99-1126. Effect of prior authorization exemption. 21
466465 (a) A healthcare insurer shall not deny or reduce payment to a 22
467466 healthcare provider for a healthcare service for which the healthcare 23
468467 provider has qualified for an exemption from prior authorization requirements 24
469468 under § 23-99-1120, including a healthcare service performed or supervised by 25
470469 another healthcare provider, if the health care provider who ordered the 26
471470 healthcare service received a prior authorization exemption based on medical 27
472471 necessity or appropriateness of care unless the healthcare provider: 28
473472 (1) Knowingly and materially misrepresented the healthcare 29
474473 service in a request for payment submitted to the healthcare insurer with the 30
475474 specific intent to deceive the healthcare insurer and obtain an unlawful 31
476475 payment from the healthcare insurer; or 32
477476 (2) Substantially failed to perform the healthcare service. 33
478477 (b) A healthcare insurer shall not conduct a retrospective review of a 34
479478 healthcare service subject to an exemption except: 35
480479 (1) To determine if the healthcare provider still qualifies for 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
481480
482481 13 03-16-2023 15:14:00 ANS167
483482
484483
485484 an exemption under § 23 -99-1120; or 1
486485 (2) If the healthcare insurer has a reaso nable cause to suspect 2
487486 a basis for denial exists under subsection (a) of this section. 3
488487 (c) For a retrospective review described by subdivision (b)(2) of this 4
489488 section, §§ 23-99-1120 — 23-99-1125 shall not modify or otherwise affect: 5
490489 (1) The requirements under or application of § 23-99-1115, 6
491490 including without limitation any time frames; or 7
492491 (2) Any other applicable law, except to prescribe the only 8
493492 circumstances under which: 9
494493 (A) A retrospective review may occur as specified by 10
495494 subdivision (b)(2) of this section; or 11
496495 (B) Payment may be denied or reduced as specified by 12
497496 subsection (a) of this section. 13
498497 (d) Beginning on January 1, 2024, a healthcare insurer shall provide 14
499498 to a healthcare provider a notice that includes a: 15
500499 (1) Statement that the healthcare provider has an exemption from 16
501500 prior authorization requirements under § 23-99-1120; 17
502501 (2) List of the healthcare services and health benefit plans to 18
503502 which the exemption applies; and 19
504503 (3) Statement of the duration of the exemption. 20
505504 (e) If a healthcare provider submits a prior authorization request for 21
506505 a healthcare service for which the healthcare provider has an exemption from 22
507506 prior authorization requirements under § 23-99-1120, the healthcare insurer 23
508507 shall promptly provide a notice to the healthcare provider that includes: 24
509508 (1) The information described in subsection (d) of this section; 25
510509 and 26
511510 (2) A notification of the healthcare insurer's payment 27
512511 requirements. 28
513512 (f) This section and §§ 23-99-1120 — 23-99-1125 shall not be construed 29
514513 to: 30
515514 (1) Authorize a healthcare provider to provide a healthcare 31
516515 service outside the scope of the healthcare provider's applicable license; or 32
517516 (2) Require a healthcare insurer to pay for a healthcare service 33
518517 described by subdivision (f)(1) of this section that is performed in 34
519518 violation of the laws of this state. 35
520519 (g) A healthcare insurer that offers multiple health benefit plans or 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
521520
522521 14 03-16-2023 15:14:00 ANS167
523522
524523
525524 that utilizes multiple healthcare provider networks shall not determine a 1
526525 healthcare provider’s eligibility for an exemption fr om prior authorization 2
527526 for each specific health benefit plan or each specific healthcare provider 3
528527 network but rather shall determine the healthcare provider’s eligibility for 4
529528 an exemption applicable to all health benefit plans and healthcare provider 5
530529 networks. 6
531530 (h) If a healthcare insurer and a healthcare provider are engaged in a 7
532531 value-based reimbursement arrangement for particular healthcare services or 8
533532 subscribers, the healthcare insurer shall not impose any prior authorization 9
534533 requirements for any part icular healthcare service that is included in that 10
535534 value-based reimbursement arrangement. 11
536535 12
537536 23-99-1127. Applicability. 13
538537 (a)(1) An organization or entity directly or indirectly providing a 14
539538 plan or services to patients under the Medicaid Provider -Led Organized Care 15
540539 Act, § 20-77-2701 et seq., or any other Medicaid -managed care program 16
541540 operating in this state is exempt from §§ 23 -99-1120 – 23-99-1126 if the 17
542541 program, without limiting the program's application to any other plan or 18
543542 program, develops a program to reduce or eliminate prior authorizations for a 19
544543 healthcare provider on or before January 1, 2025. 20
545544 (2) The Arkansas Health and Opportunity for Me Program established by 21
546545 the Arkansas Health and Opportunity for Me Act of 2021, § 23 -61-1001 et seq., 22
547546 or its successor program is exempt from §§ 23 -99-1120 – 23-99-1126, provided 23
548547 that the Arkansas Health and Opportuni ty for Me Program, without limiting the 24
549548 Arkansas Health and Opportunity for Me Program's application to any other 25
550549 plan or program, develops a program to reduce or eliminate prior 26
551550 authorizations for a healthcare provider on or before January 1, 2025. 27
552551 (3) A qualified health plan that is a health benefit plan under 28
553552 the Patient Protection and Affordable Care Act, Pub. L. No. 111 -148, and 29
554553 purchased on the Arkansas Health Insurance Marketplace created under the 30
555554 Arkansas Health Insurance Marketplace Act, § 23-61-801 et seq., for an 31
556555 individual up to four hundred percent (400%) of the federal poverty level, 32
557556 operating in this state is exempt from §§ 23-99-1120 — 23-99-1126 if the 33
558557 qualified health plan, without limiting the program's application to any 34
559558 other plan or program, develops a program to reduce or eliminate prior 35
560559 authorizations for a healthcare provider on or before January 1, 2025. 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
561560
562561 15 03-16-2023 15:14:00 ANS167
563562
564563
565564 (b)(1) The programs under subsection (a) of this section to reduce or 1
566565 eliminate prior authorization shall be: 2
567566 (A) Submitted to the State Insurance Department; and 3
568567 (B) Subject to approval by the Legislative Council. 4
569568 (2) If a program is not submitted to the department and approved 5
570569 by the Legislative Council on or before January 1, 2025, the Medicaid -managed 6
571570 care program operating in this state, the Arkansas Health and Opportunity for 7
572571 Me Program established by the Arkansas Health and Opportunity for Me Act of 8
573572 2021, § 23-61-1001 et seq., or its successor program, and qualified health 9
574573 plans under the Patient Protection and Affordable Care Act, Pub. L. No. 111 -10
575574 148, and purchased on the Arkansas Health Insurance Marketplace created under 11
576575 the Arkansas Health Insurance Marketplace Act, § 23-61-801 et seq., for an 12
577576 individual up to four hundred percent (400%) of the federal povert y level, 13
578577 operating in this state shall be subject to §§ 23 -99-1120 – 23-99-1126 and § 14
579578 23-99-1128 as of January 1, 2025. 15
580579 (c) Any state or local governmental employee plan is exempt from §§ 16
581580 23-99-1120 — 23-99-1126 and § 23-99-1128. 17
582581 (d) A health benefit p lan provided by a trust established under §§ 14 -18
583582 54-101 and 25-20-104 to provide benefits, including accident and health 19
584583 benefits, death benefits, dental benefits, and disability income benefits, is 20
585584 exempt from §§ 23-99-1120 – 23-99-1126. 21
586585 (e)(1) Prescription drugs, medicines, biological products, 22
587586 pharmaceuticals, or pharmaceutical services are exempt as a healthcare 23
588587 service for purposes of §§ 23 -99-1120 – 23-99-1126 until December 31, 2024. 24
589588 (2)(A) As of January 1, 2025, the provisions of §§ 23 -99-1120 – 25
590589 23-99-1126 shall apply to prescription drugs, medicines, biological products, 26
591590 pharmaceuticals, or pharmaceutical services that have not been approved for 27
592591 continuation of prior authorization under § 23 -99-1128. 28
593592 (B) For the products in subdivision (e)(2)(A) of this 29
594593 section that have not been approved for continuation of prior authorization, 30
595594 for purposes of § 23 -99-1120, then: 31
596595 (i) Provisions regarding time periods specified 32
597596 during the calendar year 2022 shall instead apply to the same months dur ing 33
598597 calendar year 2023; and 34
599598 (ii) Provisions regarding time periods specified 35
600599 during the calendar year 2024 shall instead apply to the same months during 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
601600
602601 16 03-16-2023 15:14:00 ANS167
603602
604603
605604 calendar year 2025. 1
606605 2
607606 23-99-1128. Prescription drugs, medicines, biological products, 3
608607 pharmaceuticals, or pharmaceutical services. 4
609608 (a)(1) Beginning on January 1, 2024, a healthcare insurer or pharmacy 5
610609 benefits manager shall submit a written request to the Arkansas State Board 6
611610 of Pharmacy for any prescription drug, medicine, biological product, 7
612611 pharmaceutical, or pharmaceutical service to be reviewed for a continuation 8
613612 of prior authorization by a specified health benefit plan whether or not a 9
614613 healthcare provider has met the criteria for an exemption from prior 10
615614 authorization under §§ 23 -99-1120 – 23-99-1126. 11
616615 (2) The request under subdivision (a)(1) of this section shall 12
617616 state the reason the request is being made for each prescription drug, 13
618617 medicine, biological product, pharmaceutical, or pharmaceutical service for 14
619618 the specified health benefit plan. 15
620619 (b) The Arkansas State Board of Pharmacy and the Arkansas State 16
621620 Medical Board, jointly, may establish criteria and procedures to review 17
622621 whether a request made under subdivision (a)(1) of this section should be 18
623622 granted for the requesting party and specifi ed health benefit plan. 19
624623 (c)(1) The Arkansas State Board of Pharmacy and the Arkansas State 20
625624 Medical Board, jointly, may determine whether or not a prescription drug, 21
626625 medicine, biological product, pharmaceutical, or pharmaceutical service may 22
627626 be subject to prior authorization by a health benefit plan under the criteria 23
628627 and procedures under subsection (b) of this section. 24
629628 (2) The Arkansas State Board of Pharmacy shall promptly notify 25
630629 the entity that made the request of the joint decision made by the Arkan sas 26
631630 State Board of Pharmacy and the Arkansas State Medical Board. 27
632631 (d) The Arkansas State Board of Pharmacy shall make available to any 28
633632 person who requests it, a list for any health benefit plan of prescription 29
634633 drugs, medicines, biological products, pharmaceuticals, or pharmaceutical 30
635634 services that require a prior authorization under this section. 31
636635 32
637636 23-99-1129. Appeals process for disallowance of prior authorization. 33
638637 (a) If the Arkansas State Board of Pharmacy and the Arkansas State 34
639638 Medical Board, jointly, disallow a prior authorization of a prescription 35
640639 drug, medicine, biological product, pharmaceutical, or pharmaceutical service 36 As Engrossed: H3/6/23 H3/9/23 S3/16/23 HB1271
641640
642641 17 03-16-2023 15:14:00 ANS167
643642
644643
645644 requested under § 23 -99-1128, a healthcare insurer, pharmacy benefits 1
646645 manager, or other interested party may file an app eal to the State Insurance 2
647646 Department within ninety (90) days of the disallowance of the prior 3
648647 authorization. 4
649648 (b) No later than the thirtieth day after the date a healthcare 5
650649 insurer, pharmacy benefits manager, or other interested party files an appeal 6
651650 under subsection (a) of this section, the Insurance Commissioner shall 7
652651 appoint an independent review organization to review the appeal. 8
653652 (c) A healthcare insurer, pharmacy benefits manager, or other 9
654653 interested party that files an appeal under subsection (a) of this section 10
655654 shall pay for the independent review organization appointed under subsection 11
656655 (b) of this section to review the appeal. 12
657656 (d) A healthcare insurer, pharmacy benefits manager, or other 13
658657 interested party is bound by the independent review organization's 14
659658 determination of the appeal under this section. 15
660659 16
661660 /s/L. Johnson 17
662661 18
663662 19
664-APPROVED: 4/11/23 20
663+ 20
665664 21
666665 22
667666 23
668667 24
669668 25
670669 26
671670 27
672671 28
673672 29
674673 30
675674 31
676675 32
677676 33
678677 34
679678 35
680679 36